|
1
|
Marioni G, Marchese-Ragona R, Cartei G,
Marchese F and Staffieri A: Current opinion in diagnosis and
treatment of laryngeal carcinoma. Cancer Treat Rev. 32:504–515.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forastiere A, Koch W, Trotti A and
Sidransky D: Head and neck cancer. N Engl J Med. 345:1890–1900.
2001. View Article : Google Scholar
|
|
3
|
Kleinsasser O: Revision of classification
of laryngeal cancer; is it long overdue? (Proposals for an improved
TN-classification). J Laryngol Otol. 106:197–204. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang Y, Gehrke S, Haque ME, et al:
Inactivation of Drosophila DJ-1 leads to impairments of oxidative
stress response and phosphatidylinoditol 3-kinase⁄Akt signaling.
Proc Natl Acad Sci USA. 102:13670–13675. 2005. View Article : Google Scholar
|
|
5
|
Nagakubo D, Taira T, Kitaura H, Ikeda M,
Tamai K, Iguchi-Ariga SM and Ariga H: DJ-1, a novel oncogene which
transforms mouse NIH3T3 cells in cooperation with ras. Biochem
Biophys Res Commun. 231:509–513. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hod Y: Differential control of apoptosis
by DJ-1 in prostate benign and cancer cells. J Cell Biochem.
92:1221–1233. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
MacKeigan JP, Clements CM, Lich JD, Pope
RM, Hod Y and Ting JP: Proteomic profiling drug-induced apoptosis
in non-small cell lung carcinoma: identification of RS/DJ-1 and
RhoGDIalpha. Cancer Res. 63:6928–6934. 2003.PubMed/NCBI
|
|
8
|
Kim RH, Peters M, Jang Y, et al: DJ-1, a
novel regulator of the tumor suppressor PTEN. Cancer Cell.
7:263–273. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu XL, Wang ZF, Lei WB, Zhuang HW, Jiang
HY and Wen WP: DJ-1: a novel independent prognostic marker for
survival in glottic squamous cell carcinoma. Cancer Sci.
101:1320–1325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen Z, Ren Y, Ye D, Guo J, Kang C and
Ding H: Significance and relationship between DJ-1 gene and
surviving gene expression in laryngeal carcinoma. Eur J Histochem.
55:e92011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu XL, Wang ZF, Lei WB, Zhuang HW, Hou
WJ, Wen YH and Wen WP: Tumorigenesis role and clinical significance
of DJ-1, a negative regulator of PTEN, in supraglottic squamous
cell carcinoma. J Exp Clin Cancer Res. 31:942012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sitaram RT, Cairney CJ, Grabowski P, Keith
WN, Hallberg B, Ljungberg B and Roos G: The PTEN regulator DJ-1 is
associated with hTERT expression in clear cell renal cell
carcinoma. Int J Cancer. 125:783–790. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee H, Choi SK and Ro JY: Overexpression
of DJ-1 and HSP90α and loss of PTEN associated with invasive
urothelial carcinoma of urinary bladder: Possible prognostic
markers. Oncol Lett. 3:507–512. 2012.PubMed/NCBI
|
|
14
|
Davidson B, Hadar R, Schlossberg A, et al:
Expression and clinical role of DJ-1, a negative regulator of PTEN,
in ovarian carcinoma. Hum Pathol. 39:87–95. 2008. View Article : Google Scholar
|
|
15
|
Weichert H, Blechschmidt I, Schröder S and
Ambrosius H: The MTT-assay as a rapid test for cell proliferation
and cell killing: application to human peripheral blood lymphocytes
(PBL). Allerg Immunol (Leipz). 37:139–144. 1991.
|
|
16
|
Sun W, Guo MM, Han P, et al: Id-1 and the
p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma
cells and are correlated with poor prognosis. Carcinogenesis.
33:810–817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He X, Zheng Z, Li J, et al: DJ-1 promotes
invasion and metastasis of pancreatic cancer cells by activating
SRC/ERK/uPA. Carcinogenesis. 33:555–562. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bai J, Guo C, Sun W, et al: DJ-1 may
contribute to metastasis of non-small cell lung cancer. Mol Biol
Rep. 39:2697–2703. 2012. View Article : Google Scholar
|
|
19
|
Le Naour F, Misek DE, Krause MC, Deneux L,
Giordano TJ, Scholl S and Hanash SM: Proteomics-based
identification of RS/DJ-1 as a novel circulating tumor antigen in
breast cancer. Clin Cancer Res. 7:3328–3335. 2001.PubMed/NCBI
|
|
20
|
Yuen HF, Chan YP, Law S, Srivastava G,
El-Tanani M, Mak TW and Chan KW: DJ-1 could predict worse prognosis
in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers
Prev. 17:3593–3602. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He XY, Liu BY, Yao WY, et al: Serum DJ-1
as a diagnostic marker and prognostic factor for pancreatic cancer.
J Dig Dis. 12:131–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Junn E, Taniguchi H, Jeong BS, Zhao X,
Ichijo H and Mouradian MM: Interaction of DJ-1 with Daxx inhibits
apoptosis signal-regulating kinase 1 activity and cell death. Proc
Natl Acad Sci USA. 102:9691–9696. 2005. View Article : Google Scholar : PubMed/NCBI
|
